Research & Development
MiniMed expands Abbott partnership for dual glucose-ketone diabetes sensors
3 June 2026 - Insulin delivery company MiniMed (NASDAQ: MMED) announced on Wednesday that it has expanded its partnership with medical device and health care company Abbott to commercialise dual gluco...
Lupin and Natco secure US FDA approval for generic Eribulin Mesylate Injection
...
Luminopia agrees international licensing deal for paediatric amblyopia treatment in Japan
3 June 2026 - Luminopia Inc, a digital health company developing a new class of treatments for neuro-visual disorders, announced on Tuesday its first international licensing agreement with ROHTO Pharm...
FDA accepts Genentech's giredestrant application for early-stage breast cancer
2 June 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), said on Tuesday that the US Food and Drug Administration (FDA) has accepted its New Drug Appli...
Amgen receives EU marketing authorisation for IMDYLLTRA in ES-SCLC
2 June 2026 - US biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Monday that it has received marketing authorisation from the European Commission for IMDYLLTRA (tarlatamab) as a monotherapy...
Haisco receives US FDA approval for anaesthetic Cipepofol
...